Pharmaceuticals in the Netherlands

MarketLine
April 30, 2014
34 Pages - SKU: MTLN5250292
Countries covered: Netherlands

Pharmaceuticals in the Netherlands

Introduction

Pharmaceuticals in the Netherlands industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2009-13, and forecast to 2018). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Netherlands pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Highlights
  • The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2013 annual average exchange rates.
  • The Dutch pharmaceuticals market had total revenues of $6.1bn in 2013, representing a compound annual rate of change (CARC) of -0.5% between 2009 and 2013.
  • The performance of the market is forecast to accelerate, with an anticipated compound annual growth rate (CAGR) of 1.2% for the five-year period 2013 - 2018, which is expected to drive the market to a value of $6.4bn by the end of 2018.
Features

Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in the Netherlands

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in the Netherlands

Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the Netherlands pharmaceuticals market with five year forecasts

Macroeconomic indicators provide insight into general trends within the Netherlands economy

Key Questions Answered

What was the size of the Netherlands pharmaceuticals market by value in 2013?

What will be the size of the Netherlands pharmaceuticals market in 2018?

What factors are affecting the strength of competition in the Netherlands pharmaceuticals market?

How has the market performed over the last five years?Who are the top competitiors in the Netherlands's pharmaceuticals market?



More Country Overviews reports by MarketLine

Pharmaceuticals: BRIC (Brazil, Russia, India, China) Industry Guide by MarketLine
Pharmaceuticals: BRIC (Brazil, Russia, India, China) Industry GuideIntroductionThe BRIC Pharmaceuticals industry guide provides top-line qualitative and quantitative summary information including: market size (value 2009-13, and ...
Pharmaceuticals: North America (NAFTA) Industry Guide by MarketLine
Pharmaceuticals: North America (NAFTA) Industry GuideIntroductionThe NAFTA Pharmaceuticals industry guide provides top-line qualitative and quantitative summary information including: market size (value 2009-13, and forecast to ...
Pharmaceuticals: Global Industry Almanac by MarketLine
Pharmaceuticals: Global Industry AlmanacIntroductionGlobal Pharmaceuticals industry guide provides top-line qualitative and quantitative summary information including: market size (value 2009-13, and forecast to 2018). The guide ...
Pharmaceuticals: Global Group of Eight (G8) Industry Guide by MarketLine
Pharmaceuticals: Global Group of Eight (G8) Industry GuideIntroductionThe G8 Pharmaceuticals industry guide provides top-line qualitative and quantitative summary information including: market size (value 2009-13, and ...
See all reports like this >>

More Netherlands Country Overviews reports

Netherlands Pharmaceuticals and Healthcare Report Q3 2014 by Business Monitor International
Netherlands Pharmaceuticals and Healthcare Report Q3 2014BMI View: Despite Netherlands' expectations for a return to positive economic growth in 2014, itsgovernment will continue with austerity ...
Netherlands Pharmaceuticals and Healthcare Report Q1 2013 by Business Monitor International
BMI View: While the Netherlands is a low-risk market from the point of view of multinationaldrugmakers, the country's modest per capita expenditure on pharmaceuticals relative ...
Netherlands Pharmaceuticals and Healthcare Report Q4 2012 by Business Monitor International
BMI View: The Netherlands remains ranked top in the 2012 version of the Euro Health Consumer Index, which is compiled by Swedish company Health Consumer ...
Netherlands Pharmaceuticals and Healthcare Report Q3 2012 by Business Monitor International
BMI View: While the Netherlands is a low risk market from the point of view of multinational drugmakers, the country’s modest per capita expenditure on ...
See all reports like this >>

More Netherlands reports

D&B Country RiskLine Report: The Netherlands by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: The Netherlands by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
See all reports like this >>

 

SELECT A LICENSE

    Online Download  USD 350  
    Global Site License  USD 875  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!